Herbal extract may treat prostate cancer

	Tweet

An olive-oil based herbal extract preparation called Zyflamend suppresses the growth of prostate cancer cells and induces prostate cancer cells to self-destruct, according to a new study.

Zyflamend has the ability, in culture at least, to reduce prostate cancer cell growth by as much as 78 percent and induce cancer cell death or “apoptosis,” scientists report in the journal Nutrition and Cancer.

“Together, these results suggest that Zyflamend might have some chemopreventive utility against prostate cancer in men,” said lead investigator Dr. Debra L. Bemis of Columbia University College of Physicians and Surgeons, New York.

Zyflamend has both COX-1 and COX-2 anti-inflammatory effects, although its anti-cancer effects against prostate cancer are independent of COX-2 inhibition. COX inhibitors have shown value for prostate cancer patients, but data from recent trials of selective COX-2 inhibitors suggest that use of these drugs might have adverse effects on the heart.

Aspirin, a non-selective COX inhibitor, is not associated with these side effects and, instead, has well established benefits in people with heart disease. Zyflamend has a biochemical action profile similar to aspirin.

In the laboratory, Bemis and colleagues observed that treatment of prostate cancer cells with Zyflamend dramatically decreased COX-1 and COX-2 enzyme activity and attenuated cancer cell growth.

Bemis said “we are currently conducting a Phase I clinical trial for men with a pre-cancerous lesion of the prostate—prostatic intraepithelial neoplasia—to gain some information as to Zyflamend’s potential to prevent or slow… progression to prostate cancer.”

SOURCE: Nutrition and Cancer, October 2005. 

RELATED STORIES:
Prostate Cancer Patients Sought for Database as Part of Joint Effort   CCNY researchers demonstrate effectiveness of contrast agent Cytate in detectcing prostate cancer   Lower detection of prostate cancer with PSA screening in US than in a European randomized trial   “Watchful waiting” safe for some prostate cancers   New, non-invasive prostate cancer test beats PSA in detecting prostate cancer, researchers report   Heavy men fare poorly with prostate cancer   PSA test alone not an ideal predictor of prostate cancer   Abbott says access to prostate cancer drug widened   University of Oklahoma Scientists Discover Way to Stop Pancreatic Cancer in Early Stages   Hops Compound May Prevent Prostate Cancer   New diagnostic tool for prostate cancer   Castrate resistant prostate cancer: New therapeutic approaches   New test can predict return of prostate cancer   Men Treated for Localized Prostate Cancer Could Benefit from Pomegranate Juice Consumption   Screening spares men from advanced prostate cancer   Study examines the use of a novel suprapubic catheter in suprapubic prostatectomy   Obese men less likely to get biopsy after PSA screening   Drug shows promise in prostate cancer spread to bone   Calcium consumption may cause prostate cancer in Chinese   Prostate cancer surgery more costly for obese men   Young men with prostate cancer benefit from radiation therapy   Men often not told of prostate cancer risks: study

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]